ManukaMed

ManukaMed is a specialized medical technology company focused on the development and commercialization of advanced wound care solutions derived from medical-grade Manuka honey. The company leverages the unique antibacterial and healing properties of Leptospermum scoparium honey, specifically ensuring high levels of Methylglyoxal (MGO) through proprietary testing and processing. Its product portfolio, which includes MANUKAhd dressings and MANUKApli gels, is designed to manage complex wounds such as diabetic foot ulcers, venous leg ulcers, and severe burns. ManukaMed's products are utilized globally by clinicians to promote autolytic debridement, reduce wound odor, and maintain a moist healing environment. Headquartered in New Zealand with a significant presence in the United States, the company maintains strict control over its supply chain from hive to hospital. This vertical integration ensures the consistency, safety, and efficacy of its bioactive wound care treatments.